Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.
Learn More
Luminex Licensed Technologies Partner Spotlight: Ampersand Biosciences
“Developing custom murine biomarker multiplexed immunoassays
Luminex Licensed Technologies Partners represent a diverse set of market segments, company sizes, and geographies. The versatility of xMAP® Technology has supported the launch of thousands of multiplexed immunoassays formatted into commercially available kits and testing services…”
Continue Reading…
The team from Galapagos NV talks about their Mission to become the largest Biotech company in Europe, and how automating the Luminex FLEXMAP 3D® system is helping with their drug discovery.
Watch more videos >
May 3
Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay
July 17
Luminex Corporation Second Quarter Earnings Release Scheduled for August 7, 2017
June 28
Luminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay
May 25
Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference
May 24
Luminex Corporation Declares Second Quarter Cash Dividend
AACC Annual Meeting & Clinical Lab Expo
July 30-August 3
San Diego, CA
SWACM Annual Meeting
September 6-9
St. Louis, MO
xMAP Connect U.S. 2017
September 19
Boston, MA
Intermountain States Seminar
September 29-30
Jackson, WY
PSI Annual Meeting
October 3
Dublin, OH
